Generated by GPT-5-mini| JACC | |
|---|---|
| Title | JACC |
| Discipline | Cardiology |
| Abbreviation | JACC |
| Publisher | American College of Cardiology |
| Country | United States |
| History | 1950s–present |
| Frequency | Weekly |
| Impact | High |
JACC
JACC is a leading peer-reviewed medical journal in cardiology associated with the American College of Cardiology, publishing clinical research, reviews, and guidelines. It serves as a primary venue for reports from major trials, consensus documents, and scientific statements that influence practice at institutions such as Mayo Clinic, Cleveland Clinic, and Johns Hopkins Hospital. The journal interacts with major trials and organizations including New England Journal of Medicine, European Society of Cardiology, American Heart Association, and regulatory decisions by the U.S. Food and Drug Administration.
JACC publishes original investigations, state-of-the-art reviews, editorials, and clinical perspectives relevant to cardiovascular medicine practiced at centers like Mount Sinai Hospital, Massachusetts General Hospital, Stanford University Medical Center, and University of Pennsylvania Health System. Its readership includes clinicians and researchers from institutions such as Harvard Medical School, University of Oxford, Imperial College London, and Karolinska Institutet. The journal complements related outlets like Circulation, European Heart Journal, The Lancet, and BMJ by focusing on translational and interventional cardiology topics that inform guidelines issued by bodies such as the World Health Organization and specialty societies including Society for Cardiovascular Angiography and Interventions.
Founded in the mid-20th century by the American College of Cardiology, the journal has chronicled developments from landmark trials like the Framingham Heart Study and the Multiple Risk Factor Intervention Trial through to modern randomized controlled trials including PARTNER (Transcatheter Aortic-Valve Replacement) and ISCHEMIA trial. Editors and contributors have included figures affiliated with Cedars-Sinai Medical Center, Columbia University Irving Medical Center, University of California, San Francisco, and Yale School of Medicine. Over decades the journal evolved alongside technological advances such as coronary angiography pioneered by researchers at Mayo Clinic and interventional techniques popularized at Heart Institute (São Paulo).
The editorial board is typically chaired by a distinguished cardiologist affiliated with a major academic center such as Johns Hopkins University School of Medicine or Duke University School of Medicine. Associate editors and statistical reviewers come from institutions including University College London, McMaster University, and Toronto General Hospital. Peer review involves external reviewers drawn from networks at institutions like Columbia University, Vanderbilt University Medical Center, University of Michigan, and Hopkins. Publication cadence is weekly, coordinating with meeting calendars for organizations such as the American College of Cardiology Annual Scientific Session and the European Society of Cardiology Congress.
The journal covers interventional cardiology, electrophysiology, heart failure, imaging, preventive cardiology, and translational basic science. Typical content includes randomized trials led by consortia at Brigham and Women's Hospital, registries coordinated with Duke Clinical Research Institute, meta-analyses by groups at Cochrane Collaboration affiliates, and guideline statements drafted with contributors from Society of Thoracic Surgeons. Imaging research often involves collaborations with centers such as Hospital for Special Surgery and technology partnerships with manufacturers that supply devices to institutions like Mayo Clinic and Cleveland Clinic.
The journal's articles are widely cited by clinical guideline committees at bodies such as the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and influence device approvals at the U.S. Food and Drug Administration. Citation metrics routinely compare it with Circulation and European Heart Journal. Major trial reports published in the journal have affected practice at hospitals including Mount Sinai, Massachusetts General Hospital, and NYU Langone Health, and have been discussed in outlets like The New York Times, The Wall Street Journal, and The Washington Post.
Notable publications have included pivotal trial reports, consensus statements on myocardial infarction care, and thematic issues on topics such as transcatheter therapies and cardio-oncology with contributions from teams at Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, and Fred Hutchinson Cancer Research Center. Special issues have coincided with meetings like the American College of Cardiology Annual Scientific Session and have showcased landmark research coordinated with registries such as the Get With The Guidelines program.
The journal is indexed in major databases including PubMed, MEDLINE, Scopus, and Web of Science, and is accessible to subscribers within hospital systems such as Kaiser Permanente and academic libraries at Oxford University and Cambridge University. Content is discoverable through platforms used by institutions like Elsevier ScienceDirect subscribers and readers at research centers including NIH intramural programs. Articles contribute to continuing medical education modules used by trainees at Johns Hopkins, University of California Los Angeles, and Emory University School of Medicine.
The journal maintains formal ties with the American College of Cardiology and collaborates with specialty journals and societies including Circulation, European Heart Journal, JAMA Cardiology, and subspecialty outlets such as Heart Rhythm and JACC: Cardiovascular Imaging. Cross-publication relationships involve editorial exchanges and coordinated guidelines with organizations like the American Heart Association and European counterparts such as the European Society of Cardiology.
Category:Cardiology journals